An apparatus for taking an intestinal sample of a human or animal patient comprises a holder part (1) and an expandable part (2) supported by the holder part and having one or more sampling areas (8) on the surface thereof. The expandable part (2) is in a non-expanded state rectally insertable into and retractable from the patient's intestine, and in an expanded state, inserted into the patient's intestine, the expandable part is capable of contacting the intestinal wall with at least one sampling area (8; 14). The apparatus further comprises protective livers (7a, 7b) for preventing said sampling area or areas (8) from contact with the intestinal wall and intestinal fluid at least when the expandable part (2) in the non-expanded state is being rectally inserted into the patient's intestine.
|
1. An apparatus for taking an intestinal sample of a human or animal patient, said apparatus comprising a holder part and an expandable part supported by the holder part, the expandable part having one or more sampling areas on the surface thereof, said expandable part in a non-expanded state thereof being adapted for rectal insertion into and retraction from a patient's intestine, and in an expanded state, when inserted into a patient's intestine, being capable of contacting an intestinal wall with at least one sampling area, the apparatus further comprising protective means for preventing said sampling area or areas from contact with an intestinal wall and intestinal fluid at least when said expandable part in the non-expanded state thereof is being rectally inserted into a patient's intestine.
24. An apparatus for taking an intestinal sample of a human or animal patient, said apparatus comprising a holder part and an expandable part supported by the holder part, the expandable part having one or more sampling areas on the surface thereof, said expandable part in a non-expanded state thereof being adapted for rectal insertion into and retraction from a patient's intestine, and in an expanded state, when inserted into a patient's intestine, being capable of contacting an intestinal wall with at least one sampling area, the apparatus further comprising a protective cover adapted to prevent said sampling area or areas from contact with an intestinal wall and intestinal fluid at least when said expandable part in the non-expanded state thereof is being rectally inserted into a patient's intestine.
25. A method for testing for allergy, comprising taking an intestinal sample of a human or animal patient using an apparatus comprising a holder part and an expandable part supported by the holder part, the expandable part having one or more sampling areas on the surface thereof, said expandable part in a non-expanded state thereof being adapted for rectal insertion into and retraction from a patient's intestine, and in an expanded state, when inserted into a patient's intestine, being capable of contacting an intestinal wall with at least one sampling area, the apparatus further comprising protective means for preventing said sampling area or areas from contact with an intestinal wall and intestinal fluid at least when said expandable part in the non-expanded state thereof is being rectally inserted into a patient's intestine, and analyzing the intestinal sample.
2. The apparatus according to
3. The apparatus according to
4. The apparatus according to
5. The apparatus according to
6. The apparatus according to
7. The apparatus according to
8. The apparatus according to
9. The apparatus according to
10. The apparatus according to
11. The apparatus according to
12. The apparatus according to
13. The apparatus according to
14. The apparatus according to
15. The apparatus according to
16. The apparatus according to
17. The apparatus according to
18. The apparatus according to
19. The apparatus according to
20. The apparatus according to
21. The apparatus according to
22. The apparatus according to
23. The apparatus according to
|
The present application claims priority under 35 U.S.C. §119(e) of U.S. provisional application Ser. No. 60/163,033 filed Nov. 2, 1999.
The present invention relates to the study of pathological changes in the gastrointestinal system, and more particularly to an apparatus for taking intestinal samples as well as to the use thereof.
Among the various techniques that are used today to study pathological changes in the gastro-intestinal system are X-ray contrast examination, computerized tomography and magnetic resonance tomography. Endoscopy, i.e. insertion into the gastrointestinal tract of a stomach or intestinal viewer (gastroscopy, colonoscopy, rectoscopy) makes it possible to inspect the intestinal wall and to take samples from the intestinal mucous membrane (biopsy) which then may be examined by e.g. microscopy. Recently, also intestinal perfusion systems have been used. All these techniques are expensive, time-consuming and more or less trying to the patient. There is therefore a need for a simple methodology that makes it possible to study pathological processes in the intestinal mucous membrane without using biopsy or perfusion.
WO 95/32668 discloses a rectal instrument to be used in allergy diagnosis and designed for insertion into the colonic tract to take samples from the lumen of the large intestine after provocation of the mucous membrane with an allergen. The instrument comprises a tube-like element having a terminal part that is expandable, specifically an inflatable balloon. Subareas on the balloon have a diffusable allergen absorbed or adsorbed thereto, and on the same or separate subareas, a receptor(s) for one or more inflammation markers, usually antibodies specific to the relevant marker(s), are bound to the balloon. The instrument is inserted into the rectum, whereupon the balloon is inflated such that the outer surface of the balloon contacts the mucous membrane. The allergen diffuses to the rectal mucous membrane and, if the individual concerned is allergic to the allergen in question, will cause the release of inflammation markers which in turn diffuse to the lumen where they eventually are captured by the receptor(s) on the balloon surface. After the marker or markers have been released and bound to the balloon, the balloon is deflated and the device is removed and analyzed with respect to the bound marker(s).
The above instrument has, however, the drawback that the areas with diffusible allergen and the areas with immobilized receptor on the balloon surface may be damaged by contact with the internal sphincter when inserted and retracted through the patient's anus. It may also be mentioned, that, generally, immobilizing receptors on the balloon surface could cause problems in that hazardous residues from the coupling of the receptor(s) may remain on the surface.
The present invention aims at overcoming the disadvantages of the prior art devices or instruments and provide an apparatus for rectal insertion for studying pathological processes in the intestinal mucous membrane without the use of biopsy or perfusion. Like the instrument described in WO 95/32668 above, the apparatus of the present invention is based on contacting an expandable part thereof with the intestinal wall for sampling, and optionally also for provocation of the intestine with allergen.
According to a basic concept of the invention, however, the sampling area(s) and provocation area(s), when present, of the expandable part essentially are protected from contact with the intestinal wall when the expandable part is inserted and retracted from the colon through the patient's anus.
The present invention therefore provides an apparatus for taking an intestinal sample in a human or animal patient, comprising a holder part and an expandable part supported by the holder part and having at least one sampling area. In a non-expanded state of the expandable part, the expandable part is rectally insertable, and in an expanded state, the sampling area or areas of the expandable part are capable of contacting the intestinal wall. The apparatus is characterized in that it comprises means for protecting the sampling area or areas from contact with the intestinal wall and intestinal fluid when the expandable part in its non-expanded state is rectally inserted into the intestinal tract.
Preferably, the apparatus comprises means for protecting the sampling area or areas also when removing the expandable part from the intestine.
While essentially the whole area of the expandable part could be a sampling area, it is preferred that one or preferably, more subareas thereof are used as sampling areas and provocation areas.
The sampling area or areas on the expandable part may have one or more receptors for, for example, an inflammation or cancer marker or the like bound to the. surface thereof (similarly as in the device described in WO 95/32668 above). Such inflammation markers may, for example, be derived from neutrophilic granulocytes, eosinophilic granulocytes, mast cells/basophilic granulocytes, or may be a cytokine, a prostaglandin or a plasma protein, such as albumin.
While the sampling area or areas in this case may have the receptor(s) immobilized directly to the surface of the expandable part, it is preferred that the sampling area or areas comprise a surface element of suitable material attached to the expandable part surface. Such a material may exhibit a two-dimensional surface to which the receptor or receptors are immobilized, or constitute a three-dimensional matrix structure in which the receptor or receptors are immobilized in depth.
Alternatively, and at least in some aspects also preferably, the sampling area or areas comprise absorbing material (without any immobilized receptor) capable of effectively sucking up water and substances dissolved therein (such as proteins, enzymes, hormones etc) when contacted with the intestinal mucosa, such that the content of such substances in the absorbed material may be analyzed. After sampling, a reactant or reactants may be added directly to the absorbing material to detect the presence of a certain substance or substances through a colour reaction or similar.
Usually, however, the absorbing material is removed from the expandable part after sampling and the absorbed substances extracted and analyzed separately by various analytical methods, such as electrophoresis, radioimmunological techniques, enzyme immunosorbent assay (ELISA) or nephelometry, just to mention a few.
While it is within the scope of the present invention that the apparatus may be designed for sampling at arbitrary sites along the intestinal tract, it is presently preferred to take samples in the lumen of the large intestine. Such sampling may, for example, advantageously be used for testing for markers for allergy, especially food allergy including e.g. celiac disease, after provoking the colonic mucosa with a desired allergen(s), e.g. gluten (as described in the above-mentioned WO 95/32668).
The expandable part is advantageously an inflatable member of a flexible or elastic material, for example a balloon or an elastic tubular member.
In one embodiment of apparatus according to the present invention, the sampling area or areas on the expandable part are protected by a protective cover until the expandable part has reached the desired section of the intestine to be studied. Prior to or after expanding the expandable part, the cover is removed, e.g. mechanically by pulling means provided on or associated with the apparatus part outside the body, to permit sampling by contacting the sampling area or areas with the intestinal wall.
In another embodiment, the sampling area or areas on the expandable part are protected by a cover which may be opened in connection with the sampling and then be re-closed over the sampling area(s) after the sampling is completed. Such a cover may, for example, be of capsule or shell type, for instance a two-part shell or capsule wherein the two parts together, preferably with some overlap, cover the sampling area(s) in the non-expanded state of the expandable part, but which are removed from and expose the sampling area(s) in the expanded state.
In still another embodiment, the expandable part is displaceably mounted (e.g. telescopically) within the holder part of the apparatus so that the expandable part is kept within the holder part during the rectal insertion and retraction of the apparatus, and brought out of the holder part at the test site to be expanded. In yet another embodiment, the sampling area or areas on the expandable part are depressed in relation to the remaining surface of the expandable part when the latter is in its non-expanded state to thereby prevent contact with the intestinal wall. If, for example, the expandable part is a balloon or elastic tube or cylinder with sampling elements on the surface, the holder part supporting the balloon or elastic tube may have a recess or recesses for receiving each sampling element when the balloon is deflated.
Like the apparatus described in WO 95/32668, the expandable part may also comprise means for allergen presentation to provoke the intestine before the sampling.
Such means may be the surface itself of the expandable part or a special element(s) having the allergen(s) diffusively bound or adsorbed thereto. The allergen-presenting area(s) will, of course, also be protected by the protective means at the same time as the sampling area(s). Optionally, the allergen-presenting area or areas may be the same as the sampling areas.
The apparatus illustrated in
The balloon 2 comprises a protective cover of flexible or resilient material. In the illustrated case, and as is best shown in
The surface of the balloon 2 (
Inflation and deflation, respectively, of the balloon 2 may be achieved by means of, for example, a syringe or a pumping device, such as a flexible or elastic ball or the like (not shown), connected to tube 4 (FIG. 1A). When inflating the balloon 2 from the deflated state shown in
If the apparatus is used for allergy tests (such as food allergy, including celiac disease), provocation of the intestine may be effected by a desired food allergen (e.g. gluten) contained in the patches 8. In such a case, the period of contact between the intestinal mucosa and the patches 8 will, of course, be longer, say 15-60 minutes.
An alternative design of the expandable part of the apparatus of the present invention is shown in
In use for taking a rectal sample in a patient to be tested, similarly as described above for embodiment in
Analysis of the absorbing material may be performed in various ways. A simple procedure is described below by way of example only. After the absorbing patches (8, 14) have been removed from the balloon (2, 12), they are immersed in an extraction buffer, e.g. cetyl-N,N,N-trimethylammonium bromide, 0.3% (w/v) in 0.9% saline. The extraction buffer may, for example, be contained in a syringe with the piston removed, e.g. 2 ml of extraction buffer in a 5 ml volume syringe. After a predetermined time, say, 1 hour, the buffer, including absorbed material contained in the patch or patches, is removed. In the case of a syringe being used, this is accomplished by re-inserting the piston into the syringe and pressing the liquid (including squeezing the patch or patches) into a suitable test container where the expelled liquid is analysed for the presence and, optionally, also quantity, of a desired analyte or desired analytes. Depending on the disease or disorder to be tested for, the analyte may, for example, be an inflammatory mediator, reflecting neutrophilic activity (e.g. myeloperoxidase), eosinophilic activity (ECP=eosinophil cationic protein), or EPO (eosinophil peroxidase or EPX), mast cell/basophilic activity (histamine or tryptase). Further possible analytes are certain cytokines (e.g. IL-6, IL-1, TNF-alfa), prostaglandins (e.g. PGE2).
While the invention has been described and pointed out with reference to operative embodiments thereof, it will be understood by those skilled in the art that various changes, modifications, substitutions and omissions can be made without departing from the spirit of the invention. It is intended therefore that the invention embraces those equivalents within the scope of the claims which follow.
Patent | Priority | Assignee | Title |
10188839, | Dec 15 2010 | COLOSPAN LTD | Systems and method for bypassing an anastomosis site |
10588608, | Aug 18 2016 | PROGENITY, INC | Sampling systems and related materials and methods |
10660784, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
10835152, | Sep 25 2014 | BIORA THERAPEUTICS, INC | Electromechanical pill device with localization capabilities |
11007356, | Nov 19 2018 | BIORA THERAPEUTICS, INC | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
11008631, | Oct 22 2013 | ILEX MEDICAL LTD | Kit and method for collecting body fluid for medical diagnosis |
11103377, | Mar 31 2021 | LUMOPOL, LLC | Irising drainage device and irising rectal catheter |
11363964, | Mar 31 2017 | BIORA THERAPEUTICS, INC | Localization systems and methods for an ingestible device |
11439802, | Nov 19 2018 | BIORA THERAPEUTICS, INC | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
11534149, | Oct 14 2014 | Colospan Ltd. | Apparatus for delivering a device to a hollow organ |
11547301, | Dec 07 2016 | BIORA THERAPEUTICS, INC | Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract |
11793420, | Sep 09 2016 | BIORA THERAPEUTICS, INC | Ingestible device for delivery of a dispensable substance |
7575927, | Sep 12 2006 | Alimenta Medical AB | Methods for diagnosing a gastrointestinal disorder in an individual |
8070736, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
8075539, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
8597266, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
8690817, | Dec 15 2010 | COLOSPAN LTD | Systems and method for bypassing an anastomosis site |
8777912, | Jul 22 2007 | C R BARD, INC | Waste management system |
8926577, | Oct 17 2006 | C R BARD, INC | Waste management system |
8992438, | Jul 07 2004 | ORIGIN SCIENCES LIMITED | Colorectal cell sampling device |
9339259, | Jul 07 2004 | Colonix Limited | Colorectal cell sampling device |
9456920, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
9463110, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
9511208, | Dec 15 2010 | COLOSPAN LTD | Systems and method for bypassing an anastomosis site |
9789291, | Dec 15 2010 | COLOSPAN LTD | Systems and method for bypassing an anastomosis site |
9855163, | Oct 17 2006 | C. R. Bard, Inc. | Waste management system |
9901487, | Mar 10 2010 | Anus crevice insert |
Patent | Priority | Assignee | Title |
3877464, | |||
4735214, | Sep 05 1986 | Gastrointestinal diagnostic capsule and method of use | |
5312343, | Nov 24 1989 | KROG, MICHAEL; HALLGREN, ROGER; RAAB, YNGVE | Device for segmental perfusion and aspiration of colon and rectum |
5983899, | Jun 01 1994 | Alimenta Medical AB | Diagnostic method for establishing food intolerance/allergy, and an instrument for use when carrying out the method |
5984860, | Mar 25 1998 | SORENSEN, HAROLD D | Pass-through duodenal enteroscopic device |
EP219461, | |||
WO9005304, | |||
WO9532668, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Oct 23 2000 | HALLGREN, ROGER | Alimenta Diagnostics AB | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 011441 | /0881 | |
Oct 26 2000 | Alimenta Diagnostics AB | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Nov 30 2006 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Jan 17 2011 | REM: Maintenance Fee Reminder Mailed. |
May 19 2011 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
May 19 2011 | M1555: 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity. |
Jan 16 2015 | REM: Maintenance Fee Reminder Mailed. |
Jun 10 2015 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Jun 10 2006 | 4 years fee payment window open |
Dec 10 2006 | 6 months grace period start (w surcharge) |
Jun 10 2007 | patent expiry (for year 4) |
Jun 10 2009 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jun 10 2010 | 8 years fee payment window open |
Dec 10 2010 | 6 months grace period start (w surcharge) |
Jun 10 2011 | patent expiry (for year 8) |
Jun 10 2013 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jun 10 2014 | 12 years fee payment window open |
Dec 10 2014 | 6 months grace period start (w surcharge) |
Jun 10 2015 | patent expiry (for year 12) |
Jun 10 2017 | 2 years to revive unintentionally abandoned end. (for year 12) |